Black Diamond Therapeutics Inc (BDTX)
3.75
+0.09
(+2.46%)
USD |
NASDAQ |
Oct 04, 16:00
3.745
0.00 (0.00%)
After-Hours: 20:00
Black Diamond Therapeutics Shareholders Equity (Annual): 116.74M for Dec. 31, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
Date | Value |
---|---|
December 31, 2023 | 116.74M |
December 31, 2022 | 115.70M |
December 31, 2021 | 195.90M |
December 31, 2020 | 307.76M |
Date | Value |
---|---|
December 31, 2019 | -47.16M |
December 31, 2018 | -15.54M |
December 31, 2017 | -6.675M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
-47.16M
Minimum
2019
307.76M
Maximum
2020
137.79M
Average
116.74M
Median
2023
Shareholders Equity (Annual) Benchmarks
Regeneron Pharmaceuticals Inc | 25.97B |
Ligand Pharmaceuticals Inc | 700.91M |
Agios Pharmaceuticals Inc | 811.02M |
ADMA Biologics Inc | 135.21M |
AnaptysBio Inc | 88.10M |